Distribution and temporal evolution of pharmaceutically active compounds alongside sewage sludge treatment. Risk assessment of sludge application onto soils

Journal of Environmental Management

Volumn 102, Issue , 2012, Pages 18-25

  Martín, Julia ^a   Camacho Muñoz, Ma Dolores ^a   Santos, Juan Luis ^a   Aparicio, Irene ^a   Alonso, Esteban ^a  

^a UNIVERSITY OF SEVILLE   (Spain)

Author keywords

Environmental risk assessment; Pharmaceutically active compound; Sludge treatment; Temporal evolution

Indexed keywords

COMPOSTING; RISK ASSESSMENT; SEWAGE SLUDGE; WASTEWATER TREATMENT;

CONCENTRATION LEVELS; DIGESTED SLUDGES; ECOTOXICOLOGICAL RISKS; ENVIRONMENTAL RISK ASSESSMENT; GROUP FIVES; PHARMACEUTICALLY ACTIVE COMPOUNDS; RISKS ASSESSMENTS; SEWAGE SLUDGE TREATMENT; SLUDGE TREATMENT; TEMPORAL EVOLUTION;

SOILS;

AGENTS AFFECTING LIPID METABOLISM; ANTIBIOTIC AGENT; ANTICONVULSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CAFFEINE; CARBAMAZEPINE; CLOFIBRIC ACID; DICLOFENAC; ESTRADIOL; ESTRIOL; ESTROGEN; ESTRONE; ETHINYLESTRADIOL; GEMFIBROZIL; IBUPROFEN; KETOPROFEN; NAPROXEN; NONSTEROID ANTIINFLAMMATORY AGENT; PROPRANOLOL; SALICYLIC ACID; SULFAMETHOXAZOLE; TRIMETHOPRIM;

COMPOST; CONCENTRATION (COMPOSITION); DRUG; ECOTOXICOLOGY; ENVIRONMENTAL RISK; ESTROGENIC COMPOUND; LIPID; MICROBIAL ACTIVITY; RISK ASSESSMENT; SEWAGE TREATMENT; SLUDGE; TEMPORAL EVOLUTION;

ARTICLE; ECOTOXICOLOGY; RISK ASSESSMENT; SEASONAL VARIATION; SLUDGE DIGESTION; SLUDGE TREATMENT; SUMMER; WINTER;

EID: 84862818131     PISSN: 03014797     EISSN: 10958630     Source Type: Journal    
DOI: 10.1016/j.jenvman.2012.02.020     Document Type: Article

References (44)

1. Aga D.S. Fate of Pharmaceuticals in the Environment and in Water Treatment System 2008, Taylor Francis Group, London, New York. first ed.
2. Andersen H.R., Hansen M., Kjølholt J., Stuer-Lauridsen F., Ternes T., Halling-Sørensen B. Assessment of the importance of sorption for steroid estrogens removal during activated sludge treatment. Chemosphere 2005, 61:139-146.
3. Aparicio I., Santos J.L., Alonso E. Limitation of the concentration of organic pollutants in sewage sludge for agricultural purposes: a case study in South Spain. Waste Manage. 2009, 29:1747-1753.
4. Barron L., Tobin J., Paull B. Multi-residue determination of pharmaceuticals in sludge and sludge enriched soils using pressurized liquid extraction, solid phase extraction and liquid chromatography with tandem mass spectrometry. J. Environ. Monit. 2008, 10:353-361.
5. Barron L., Purcell M., Havel J., Thomas K., Tobin J., Paull B. Occurrence and Fate of Pharmaceuticals and Personal Care Products within Sewage Sludge and Sludge-enriched Soils, 2005-FS-30-M2 STRIVE Report 2009, Environmental Protection Agency, Dublin, Ireland, 73 pp.
6. Carballa M., Omil F., Lema J. Comparison of predicted and measured concentrations of selected pharmaceuticals, fragrances and hormones in Spanish sewage. Chemposphere 2008, 72:1118-1123.
7. Chiu T.Y., Koh Y.K.K., Paterakis N., Boobis A.R., Cartmell E., Richards K.H., Lester J.N., Scrimshaw M.D. The significance of sample mass in the analysis of steroid estrogens in sewage sludges and the derivation of partition coefficients in wastewaters. J. Chromatogr. A 2009, 1216:4923-4926.
8. Clara M., Strenn B., Kreuzinger N. Carbamazepine as a possible anthropogenic marker in the aquatic environment: investigations on the behaviour of Carbamazepine in wastewater treatment and during groundwater infiltration. Water Res. 2004, 38:947-954.
9. Clarke B.O., Smith S.R. Review of 'emerging' organic contaminants in biosolids and assessment of international research priorities for the agricultural use of biosolids. Environ. Int. 2011, 36:226-247.
10. Diaz-Cruz M.S., López De Alda M.J., Barcelo D. Environmental behavior and analysis of veterinary and human drugs in soils, sediments and sludge. Trends Anal. Chem. 2003, 22:340-351.
11. Drillia P., Stamatelatou K., Lyberatos G. Fate and mobility of pharmaceuticals in solid matrices. Chemosphere 2005, 60:1034-1044.
12. EC Technical Guidance Documents in Support of the Commission Directive 93/667/EEC on Risk Assessment for New Notified Substances and the Commission Regulation (EC) 1488/94 on Risk Substances 1996, European Chemical Bureau, Ispra, Italy, 19th April 1996, part 1, 2 and 3.
13. EC Technical Guidance Document on Risk Assessment, Part II 2003, EUR 20418 EN/2, European Commision, Joint Research Centre.
14. EU Working Document on Sludge 27 April 2000, Third Draft, European Union, Brussels, Belgium.
15. Göbel A., Thomsen A., McArdell C.S., Alder A.C., Giger W., Theiß N., Löffler D., Ternes T.A. Extraction and determination of sulfonamides, macrolides, and trimethoprim in sewage sludge. J. Chromatogr. A 2005, 1085:179-189.
16. Hernando M.D., Mezcua M., Fernández-Alba A.R., Barceló D. Environmental risk assessment of pharmaceutical residues in wastewater effluents, surface waters and sediments. Talanta 2006, 69:334-342.
17. Jacobsen B.N., Kjersgaard D., Winther-Nielsen M., Gustavson K. Combined chemical analyses and biomonitoring at Avedoere wastewater treatment plant in 2002. Water Sci. Technol. 2004, 50:37-43.
18. Jelic A., Gros M., Ginebreda A., Cespedes-Sánchez R., Ventura F., Petrovic M., Barcelo D. Occurrence, partition and removal of pharmaceuticals in sewage water and sludge during wastewater treatment. Water Res. 2011, 45:1161-1176.
19. Khan S.J., Ongerth J.E. Estimation of pharmaceutical residues in primary and secondary sewage sludge based on quantities of use and fugacity modelling. Water Sci. Technol. 2002, 46:105-113.
20. Krascsenits Z., Hiller E., Bartal M. Distribution of four human pharmaceuticals, carbamazepine, diclofenac, gemfibrozil, and ibuprofen between sediment and water. J. Hydrol. Hydromech. 2008, 56(4):237-246.
21. Langdon K.A., Warne M.S.J., Kookana R.S. Aquatic hazard assessment for pharmaceuticals, personal care products and endocrine disrupting compounds from biosolids-amended land. Integr. Environ. Assess. Manage. 2010, 6:663-676.
22. Langford K.H., Reid M., Thomas K.V. Multi-residue screening of prioritised human pharmaceuticals, illicit drugs and bactericides in sediments and sludge. J. Environ. Monit. 2011, 13:2284-2291.
23. López de Alda M.J., Gil A., Paz E., Barceló, D. Occurrence and analysis of estrogens and progestogens in river sediments by liquid chromatography-electrospray-mass-spectrometry. Analyst 2002, 127:1299-1304.
24. Magoarou P. Urban Waste Water in Europe what about the Sludge? 2000, European Commission, Joint Research Centre, EUR 19657 EN.
25. Martín J., Santos J.L., Aparicio I., Alonso E. Multi-residue method for the analysis of pharmaceutical compounds in sewage sludge, compost and sediments by sonication-assisted extraction and LC determination. J. Sep. Sci. 2010, 33:1760-1766.
26. McClellan K., Halden R.U. Pharmaceuticals and personal care products in Archived U.S. Biosolids from the 2001 EPA National sewage sludge Survey. Water Res. 2010, 44:658-668.
27. MMA II Plan Nacional de lodos de depuradoras de aguas Residuales-EDAR II PNLD (2007-2015) 2006, Ministerio de Medio Ambiente, Madrid, Spain, (February 13, 2012). http://www.mma.es/secciones/calidad_contaminacion/residuos/planificacion_residuos/pdf/borradorpnir_anexo5.pdf.
28. Muller M., Combalbert S., Delgenès N., Bergheaud V., Rocher V., Benoît P., Delgenès J.P., Patureau D., Hernandez-Raquet G. Occurrence of estrogens in sewage sludge and their fate during plant-scale anaerobic digestion. Chemosphere 2010, 81:65-71.
29. Okuda T., Yamashita N., Tanaka H., Matsukawa H., Tanabe K. Development of extraction method of pharmaceuticals and their occurrences found in Japanese wastewater treatment plants. Environ. Int. 2009, 35:815-820.
30. Paterakis N., Chiu T.Y., Koh K.K., Lester J.N., McAdam E., Scrimshaw M.D., Soares A., Cartmell E. The effectiveness of anaerobic digestion in removing estrogens and nonylphenol ethoxylates. J. Hazard. Mat. 2012, 199:88-95.
31. Radjenovic J., Petrovic M., Barcelo D. Fate and distribution of pharmaceuticals in wastewater and sewage sludge of the conventional activated sludge (CAS) and advanced membrane bioreactor (MBR) treatment. Water Res. 2009, 43:831-841.
32. Saleh A., Larsson E., Yamini Y., Jönsson J.Å. Hollow fiber liquid phase microextraction as a preconcentration and clean-up step after pressurized hot water extraction for the determination of non-steroidal anti-inflammatory drugs in sewage sludge. J. Chromatogr. A 2011, 1218:1331-1339.
33. Salgado, R., Marques, R., Noronha, J., Carvalho, G., Oehmen, A., Reis, M., Assessing the removal of pharmaceuticals and personal care products in a full-scale activated sludge plant. Environ. Sci. Poll. Res., doi:10.1007/s11356-011-0693-z.
34. Sarmah A.K., Northcott G.L., Scherr F.F. Retention of estrogenic steroid hormones by selected New Zealand soils. Environ. Int. 2008, 34(6):749-755.
35. Shafrir, M., Avisar, D., Development Method for Extracting and Analyzing Antibiotic and Hormone Residues from Treated Wastewater Sludge and Composted Biosolids. Water, Air, & Soil Poll., doi:10.1007/s11270-011-1049-5.
36. Sim W.J., Lee J.W., Shin S.K., Song K.B., Oh J.E. Assessment of fates of estrogens in wastewater and sludge from various types of wastewater treatment plants. Chemosphere 2011, 82:1448-1453.
37. Spongberg A.L., Witter J.D. Pharmaceutical compounds in the wastewater process stream in Northwest Ohio. Sci. Total Environ. 2008, 397:148-157.
38. Stevens-Garmon J., Drewes J.E., Khan S.J., McDonald J.A., Dickenson E.R.V. Sorption of emerging trace organic compounds onto wastewater sludge solids. Water Res. 2011, 45:3417-3426.
39. Stuer-Lauridsen F., Birkved M., Hansen L.P., Holten Lützhøft H.C., Halling-Sørensen B. Environmental risk assessment of human pharmaceuticals in Denmark after normal therapeutic use. Chemosphere 2000, 40(7):783-793.
40. Urase T., Kikuta T. Separate estimation of adsorption and degradation of pharmaceutical substances and estrogens in the activated sludge process. Water Res. 2005, 39:1289-1300.
41. Vázquez-Roig P., Segarra R., Blasco C., Andreu V., Picó Y. Determination of pharmaceuticals in soils and sediments by pressurized liquid extraction and liquid chromatography tandem mass spectrometry. J. Chromatogr. A 2009, 1217:2471-2483.
42. Xu J., Wu L., Chen W., Chang A.C. Simultaneous determination of pharmaceuticals, endocrine disrupting compounds and hormone in soils by gas chromatography-mass spectrometry. J. Chromatogr. A 2008, 1202:189-195.
43. Yong Y., Laosheng W. Analysis of endocrine disrupting compounds, pharmaceuticals and personal care products in sewage sludge by gas chromatography-mass spectrometry. Talanta 2012, 89:258-263.
44. Yu Y., Wu L. Analysis of endocrine disrupting compounds, pharmaceuticals and personal care products in sewage sludge by gas chromatography-mass spectrometry. Talanta 2012, 89:258-263.